Henry Schein

HSIC

Medical - Distribution · Healthcare

Also trades as: 0L3C.L

Exchange

NASDAQ

Winston Score

Winston is curious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Jun 27, 2026

How the score breaks down

Quality

Mixed

Growth

Good

Cash Flow

Strong

Stability

Good

Valuation

Strong

Track this stock — start free trial

Winston Score History

The full picture

Henry Schein is a distributor of healthcare products and services, mainly selling dental and medical supplies to private practice offices, clinics, and hospitals. Its customers are mostly dentists, physicians, and other healthcare providers who need everyday items like dental instruments, medications, vaccines, and office equipment. Henry Schein is one of the largest distributors of healthcare products to office-based practitioners in the world.

The company makes money by selling physical products at a markup and also earns revenue from software, technology services, and equipment financing aimed at healthcare practices. It operates across North America, Europe, and other international markets, generating roughly $12–13 billion in annual revenue. Its main competitive advantage is its large distribution network and deep relationships with small private practices, which are harder for big-box retailers to serve. A key risk is that consolidation among dental and medical practices could reduce the number of independent customers Henry Schein depends on.

Politician Trades

4 trades / 12mo

2 Congressional buys and 2 sells on HSIC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+6.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+16.9% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

19.4%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

$157M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Henry Schein is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

31.8%

Modest — 31.8% gross margin

Profit after running costs

Operating Margin

5.8%

Thin — 5.8% operating margin

Return on the money invested

ROCE

11.7%

Below par — 11.7% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+6.5%

Slow sales growth (+6.5% YoY)

Profit growth

EPS YoY

+10.2%

Earnings growing (+10.2% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

174%

Turns 174% of profit into real cash

Spare cash per sale

FCF Margin

4.0%

Thin free cash flow (4.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.10

Elevated debt (1.10)

Covers its interest

Interest Cover

4.87x

Adequate interest coverage (4.9x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

25.6x

no trend

Growth-priced — P/E 25.6

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

+10.3

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (25.6 → 15.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial